Roflumilast 500 Mcg Oral Tablet
Sponsors
Johns Hopkins University, Jacob Pontoppidan Thyssen, University of Arizona, Tanta University, Eman Raafat Said
Conditions
AsthmaCAR T-Cell TherapyCell TherapyChronic Hand EczemaDonor Lymphocyte InfusionFlexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital PsoriasisHematopoetic Stem Cell TransplantationLeukemia
Early Phase 1
Phase 2
Trial of Roflumilast in Asthma Management (TRIM)
CompletedNCT03532490
Start: 2018-08-03End: 2021-07-30Updated: 2022-10-06
Evaluating the Efficacy and Safety of Roflumilast in Patients with NASH
CompletedNCT06677788
Start: 2022-04-01End: 2024-10-15Updated: 2024-11-07
EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL.
Not yet recruitingNCT07543640
Start: 2026-04-01End: 2026-08-01Target: 56Updated: 2026-04-22